|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3800 USD | -28.30% |
|
-28.29% | -15.56% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 21.75L 19.14L 17.78L 16.33L 30.65L 21Cr 31.16L 2.11Cr 82.79L 10Cr 81.64L 79.88L 36Cr | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.35Cr 1.19Cr 1.1Cr 1.01Cr 1.9Cr 130.17Cr 1.93Cr 13Cr 5.13Cr 64Cr 5.06Cr 4.95Cr 220.82Cr | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -28.30% | ||
| 1 week | -28.29% | ||
| Current month | -12.46% | ||
| 1 month | -26.85% | ||
| 3 months | -2.34% | ||
| 6 months | -9.52% | ||
| Current year | -15.56% |
| 1 week | 0.38 |  | 0.53 |
| 1 month | 0.38 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.30% | -28.29% | -9.52% | -58.10% | 38.4L | |
| +0.86% | +2.30% | +49.71% | +158.86% | 1,05700Cr | |
| +1.59% | +5.37% | +55.77% | +54.77% | 62TCr | |
| +0.95% | +1.95% | +36.11% | +80.44% | 45TCr | |
| +1.60% | +7.09% | +35.90% | +29.32% | 34TCr | |
| -0.60% | +2.95% | +36.28% | +39.04% | 30TCr | |
| -0.14% | +0.33% | +18.70% | +17.64% | 26TCr | |
| +0.09% | -4.53% | -27.60% | -42.19% | 22TCr | |
| +1.22% | +1.20% | +21.61% | +60.14% | 20TCr | |
| -1.18% | -5.13% | +13.87% | +60.35% | 16TCr | |
| Average | -2.53% | +0.70% | +23.08% | +40.03% | 36.14TCr | |
| Weighted average by Cap. | +0.28% | +1.57% | +36.61% | +76.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.31Cr 2.03Cr 1.89Cr 1.73Cr 3.25Cr 222.76Cr 3.31Cr 22Cr 8.78Cr 109.19Cr 8.66Cr 8.47Cr 377.88Cr | 2.42Cr 2.13Cr 1.98Cr 1.82Cr 3.41Cr 233.8Cr 3.47Cr 24Cr 9.22Cr 114.61Cr 9.09Cr 8.89Cr 396.62Cr |
| Net income | -52.67L -46.34L -43.07L -39.55L -74.22L -51Cr -75.47L -5.11Cr -2Cr -25Cr -1.98Cr -1.93Cr -86Cr | -32.03L -28.18L -26.19L -24.05L -45.14L -31Cr -45.89L -3.11Cr -1.22Cr -15Cr -1.2Cr -1.18Cr -52Cr |
| Net Debt | 1.02Cr 89.72L 83.38L 76.56L 1.44Cr 98Cr 1.46Cr 9.9Cr 3.88Cr 48Cr 3.83Cr 3.75Cr 167.02Cr | 1.13Cr 99.49L 92.46L 84.89L 1.59Cr 109.17Cr 1.62Cr 11Cr 4.3Cr 54Cr 4.24Cr 4.15Cr 185.2Cr |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $0.5297 | -0.02% | 12,014 |
| 20/26/20 | $0.5298 | -0.02% | 1,532 |
| 16/26/16 | $0.5299 | +3.90% | 4,905 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
